Thompson Reuters Business Models Event
Managing the Trademark Asset Lifecycle

Tweets

July 30

"Name calling ... simply is of no moment to me. I embrace it," says Erich Spangenberg of Celgene IPR motion. http://t.co/BDzcL7Z45T

July 30

US consumers subsidise wealthy Europeans. https://t.co/wGZhryaaCn

July 30

IAM exclusive: Spangenberg responds to Celgene IPR motion $CELG http://t.co/BDzcL7Z45T

Blog

30 Jul 2015
Spangenberg on latest big pharma filing: “This tells me I’m on to something important”

Yesterday the pharmaceutical company Celgene filed a motion for sanctions against Kyle Bass and Erich Spangenberg and their Coalition for Affordable Drugs, accusing them of abusing the inter partes review (IPR) process. In what has quickly become the patent story of the year Bass and Spangenberg have filed a series of IPRs against what they see as weak pharmaceutical patents that should never...

30 Jul 2015
Brazil joins India as a jurisdiction in which patent-light Chinese smartphone makers may fear to tread

It increasingly looks like we are on the cusp of entering a second round of smartphone patent wars, driven by the expansion of China’s fast-moving, lower-end mobile device manufacturers outside of their home markets. Earlier this month, Brazil’s competition regulator – the Conselho Administrativo de Defesa Economica (CADE) – handed down a decision that underlines just...

28 Jul 2015
New court filings throw light on ZTE’s “PR battle” with Vringo

The multi-year, worldwide and ongoing litigation battle between ZTE and non-practising entity (NPE) Vringo took an interesting twist last week when a series of internal ZTE documents were filed with a New York court. The documents, which largely consist of communications between ZTE staff, detail how the Chinese telecom company has set out to wage a “PR battle” against Vringo as...

Explore the current issue

No longer just for defendants

Invalidity studies have emerged as a valuable resource for patent monetisation, management and investment, and are increasingly being used by rights holders and even potential buyers

The world's leading patent practitioners

IAM Patent 1000

The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.

Visit site

The world's leading IP strategists

IAM Strategy 300

A directory of individuals identified following a detailed research process as global leaders in providing IP value creation expertise to rights owners.

Visit site
Market intelligence

Market intelligence

Annual IAM supplements and management reports that take an in-depth look at specific areas of IP value creation concern and opportunity.

Visit site
IPBC

IPBC

Unique in the global IP marketplace, IPBC events bring together corporate leaders, aggregators, investors and other intermediaries to discuss key issues, network and do deals.

Visit site
IP Hall of Fame

IP Hall of Fame

A project designed to recognise the outstanding contributions that individual men and women have made towards the creation of today’s global IP system.

Visit site
Upcoming event

Upcoming event

IPBC Asia, November 8-10 2015 – Tokyo, Japan This is the only event in the region that focuses on how IP owners can strategically use intellectual property to secure greater operational flexibility, drive revenues, enhance bottom-line returns, increase shareholder value and provide leverage in the financial markets.

View all events
Subscribe

Subscribe

IAM is a unique publication which focuses on the many ways in which intellectual property and intangible assets can be used to create corporate value.

Subscribe now
International reports

International reports

Weekly updates from IAM’s team of international correspondents looking at recent developments in IP law and practice, business and finance.

Visit site